Gaukhar Mergenova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gaukhar Mergenova has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Assel Terlikbayeva
Global Health Research Center of Central Asia, Almaty, Kazakhstan
17 shared publications - Sholpan Primbetova
Global Health Research Center of Central Asia, Almaty, Kazakhstan
13 shared publications - Alissa Davis
School of Social Work, Columbia University, New York, USA
10 shared publications - Elwin Wu
School of Social Work, Columbia University, New York, USA
8 shared publications - Yong Gun Lee
The University of Hong Kong, Hong Kong
8 shared publications - Emily Allen Paine
Department of Psychiatry, Columbia University, New York, NY, USA
7 shared publications
Latest Publications
- 17 April 2026
- Published by Springer Nature in AIDS and Behavior
HIV and Other Sexually Transmitted Infections Among Men and Transgender/Gender Expansive Individuals Who Have Sex with Men in Kazakhstan: Associations with HIV Stigma, Internalized Homophobia, and Community Connectedness
Since 2010, Kazakhstan has experienced an increase in HIV transmission. Men and transgender/gender-expansive people who have sex with men (MSM and TSM) carry a disproportionate HIV burden. Building on Paine et al. (2021), which linked HIV testing to stigma, internalized homophobia, and sexual- and gender-expansive (SGE) community connectedness-this brief report examined biologically confirmed HIV and other sexually transmitted infections (STIs). SGE connectedness was significantly associated with HIV infection, while HIV stigma and internalized homophobia were significantly associated with STIs. Interventions reducing stigma and strengthening SGE community ties may curb HIV and STI transmission among MSM and TSM in Kazakhstan.
- 17 April 2026
- Published by Springer Nature in AIDS and Behavior
HIV and Other Sexually Transmitted Infections Among Men and Transgender/Gender Expansive Individuals Who Have Sex with Men in Kazakhstan: Associations with HIV Stigma, Internalized Homophobia, and Community Connectedness
Since 2010, Kazakhstan has experienced an increase in HIV transmission. Men and transgender/gender-expansive people who have sex with men (MSM and TSM) carry a disproportionate HIV burden. Building on Paine et al. (2021), which linked HIV testing to stigma, internalized homophobia, and sexual- and gender-expansive (SGE) community connectedness-this brief report examined biologically confirmed HIV and other sexually transmitted infections (STIs). SGE connectedness was significantly associated with HIV infection, while HIV stigma and internalized homophobia were significantly associated with STIs. Interventions reducing stigma and strengthening SGE community ties may curb HIV and STI transmission among MSM and TSM in Kazakhstan.
- 31 October 2025
- Published by Taylor & Francis in International Journal of Transgender Health
- Vol. 27 (5) , 1-9
Toward leaving no one behind: HIV infection among trans communities in Kazakhstan
- 31 October 2025
- Published by Taylor & Francis in International Journal of Transgender Health
- Vol. 27 (5) , 1-9
Toward leaving no one behind: HIV infection among trans communities in Kazakhstan
- 17 August 2025
- Published by SAGE Publications in Health Education & Behavior
- Vol. 53 (1) , 92-97
COVID-19-Related Diminished Peer HIV Communication Intentions Among Sexual and Gender Expansive Individuals in Kazakhstan
The COVID-19 pandemic disrupted HIV service use among sexual and gender expansive (SGE) individuals in Kazakhstan and could further erode other key behavioral dimensions of HIV prevention, such as peer HIV communication intentions. We examined the association between COVID-19 disruptions to HIV service use and behavioral intention of peer HIV communication among SGE individuals enrolled in an HIV prevention trial in Kazakhstan, using data from the first 6 months of COVID-19 disruptions assessment (May–October 2020). Among 455 participants retained in the clinical trial during this period, 101 (22%) reported any COVID-19-induced disruption to HIV service use and 212 (47%) fell in the low-range intention of peer HIV communication. Being in the low-range intention was positively associated with reporting HIV service use disruptions, especially among SGE individuals living with HIV. Study findings warrant efforts of to address pandemic disruptions when promoting and sustaining peer HIV communication among MSM and TSM in Kazakhstan.
- 17 August 2025
- Published by SAGE Publications in Health Education & Behavior
- Vol. 53 (1) , 92-97
COVID-19-Related Diminished Peer HIV Communication Intentions Among Sexual and Gender Expansive Individuals in Kazakhstan
The COVID-19 pandemic disrupted HIV service use among sexual and gender expansive (SGE) individuals in Kazakhstan and could further erode other key behavioral dimensions of HIV prevention, such as peer HIV communication intentions. We examined the association between COVID-19 disruptions to HIV service use and behavioral intention of peer HIV communication among SGE individuals enrolled in an HIV prevention trial in Kazakhstan, using data from the first 6 months of COVID-19 disruptions assessment (May–October 2020). Among 455 participants retained in the clinical trial during this period, 101 (22%) reported any COVID-19-induced disruption to HIV service use and 212 (47%) fell in the low-range intention of peer HIV communication. Being in the low-range intention was positively associated with reporting HIV service use disruptions, especially among SGE individuals living with HIV. Study findings warrant efforts of to address pandemic disruptions when promoting and sustaining peer HIV communication among MSM and TSM in Kazakhstan.
- 1 July 2025
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 99 (3) , 239-247
Social Impacts of Multi-City HIV Research Participation Among Sexual and Gender Expansive Individuals in Kazakhstan
Background: Sexual and gender expansive (SGE) individuals in Kazakhstan are disproportionately affected by HIV yet stigma and discrimination pose ethical and practical challenges for HIV prevention research involving them. Although researchers are tasked with ensuring that risks of research participation are reasonable in relation to its benefits, participant-reported risks and benefits of research participation—including negative (NSIs) and positive social impacts (PSIs) on personal relationships, social status, health, and other life domains—among SGE populations have received little attention. Methods: We examined NSIs and PSIs of research participation among SGE individuals in a three-city HIV prevention study in Kazakhstan at the trial’s follow-up visits. We analyzed responses from 579 unique participants who completed a total of 2648 follow-up visits over the 36-month study period (2019–2022). Results: Overall, NSIs were rare: 9 (2%) participants reported NSIs during the study; nearly no NSIs ( =0.0037, SD=0.03) were reported at follow-up visits. These few NSIs included ‘trouble with friends, family, or acquaintances’ and ‘other’. By contrast, PSIs were extensive: 515 (89%) participants reported PSIs during the study; an average of almost five PSIs ( =4.8, SD=3.4) were reported at follow-up visits. The most frequently reported PSIs were ‘gained knowledge’, ‘improvement in HIV-related issues’, and ‘improvement in mental health’. Conclusions: Our findings demonstrate the potential for HIV prevention research to be associated with PSIs for SGE individuals experiencing stigmatization and discrimination. Future research should address NSIs, particularly confidentiality breaches and interpersonal challenges, within HIV prevention research to minimize risks and burdens of participation.
- 1 July 2025
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 99 (3) , 239-247
Social Impacts of Multi-City HIV Research Participation Among Sexual and Gender Expansive Individuals in Kazakhstan
Background: Sexual and gender expansive (SGE) individuals in Kazakhstan are disproportionately affected by HIV yet stigma and discrimination pose ethical and practical challenges for HIV prevention research involving them. Although researchers are tasked with ensuring that risks of research participation are reasonable in relation to its benefits, participant-reported risks and benefits of research participation—including negative (NSIs) and positive social impacts (PSIs) on personal relationships, social status, health, and other life domains—among SGE populations have received little attention. Methods: We examined NSIs and PSIs of research participation among SGE individuals in a three-city HIV prevention study in Kazakhstan at the trial’s follow-up visits. We analyzed responses from 579 unique participants who completed a total of 2648 follow-up visits over the 36-month study period (2019–2022). Results: Overall, NSIs were rare: 9 (2%) participants reported NSIs during the study; nearly no NSIs ( =0.0037, SD=0.03) were reported at follow-up visits. These few NSIs included ‘trouble with friends, family, or acquaintances’ and ‘other’. By contrast, PSIs were extensive: 515 (89%) participants reported PSIs during the study; an average of almost five PSIs ( =4.8, SD=3.4) were reported at follow-up visits. The most frequently reported PSIs were ‘gained knowledge’, ‘improvement in HIV-related issues’, and ‘improvement in mental health’. Conclusions: Our findings demonstrate the potential for HIV prevention research to be associated with PSIs for SGE individuals experiencing stigmatization and discrimination. Future research should address NSIs, particularly confidentiality breaches and interpersonal challenges, within HIV prevention research to minimize risks and burdens of participation.
- Open Access
- 28 May 2025
- Published by University Libraries, University at Albany, State University of New York
Social support and risky sexual behavior among male migrant market workers from Central Asia in Almaty, Kazakhstan
Background: Many studies have shown that risky sexual behavior leads to increased rates of HIV infection among labor migrants. However, little is known about the role of social support in risky sexual behavior among labor migrants in Kazakhstan. This study explores the potential association between social support and risky sexual behaviors among male migrant market vendors in Almaty, Kazakhstan.
- 28 May 2025
- Published by University Libraries, University at Albany, State University of New York
Open AccessSocial support and risky sexual behavior among male migrant market workers from Central Asia in Almaty, Kazakhstan
Background: Many studies have shown that risky sexual behavior leads to increased rates of HIV infection among labor migrants. However, little is known about the role of social support in risky sexual behavior among labor migrants in Kazakhstan. This study explores the potential association between social support and risky sexual behaviors among male migrant market vendors in Almaty, Kazakhstan.
- Open Access
- 1 April 2025
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 24
Determinants of COVID-19 Vaccine Uptake Among People Living with Human Immunodeficiency Virus
Background: Human immunodeficiency virus (HIV) cases are rising in Central Asia and Kazakhstan. People living with HIV (PLWH) in Kazakhstan are at heightened risk of severe COVID-19. We conducted a study to evaluate determinants of COVID-19 vaccine uptake among PLWH in Kazakhstan. Methods: In this cross-sectional study, 196 PLWH were recruited from the Almaty City AIDS Center (July 2022-January 2023). We used logistic regression to evaluate how multilevel factors are associated with COVID-19 vaccine uptake among PLWH in Kazakhstan. Results: COVID-19 vaccine non-uptake was associated with higher HIV stigma scores (AOR = 1.08, 95%CI:1.02,1.16, P = 0.017), a lower level of education (AOR = 2.53, 95%CI: 1.04,6.17, P = 0.0412), and never receiving the flu vaccine (AOR = 15.64, 95%CI:3.66,66.89, P = 0.0002). Participants with at least mild anxiety symptoms (AOR = 0.15, 95%CI:0.03,0.64, P = 0.0107) and a positive attitude towards vaccination (AOR = 0.79, 95%CI: 0.73,0.86, P < 0.0001) were less likely to remain unvaccinated against COVID-19. Conclusions: COVID-19 vaccination campaigns should be tailored for PLWH and incorporate stigma reduction interventions within healthcare settings.
- 1 April 2025
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 24
Open AccessDeterminants of COVID-19 Vaccine Uptake Among People Living with Human Immunodeficiency Virus
Background: Human immunodeficiency virus (HIV) cases are rising in Central Asia and Kazakhstan. People living with HIV (PLWH) in Kazakhstan are at heightened risk of severe COVID-19. We conducted a study to evaluate determinants of COVID-19 vaccine uptake among PLWH in Kazakhstan. Methods: In this cross-sectional study, 196 PLWH were recruited from the Almaty City AIDS Center (July 2022-January 2023). We used logistic regression to evaluate how multilevel factors are associated with COVID-19 vaccine uptake among PLWH in Kazakhstan. Results: COVID-19 vaccine non-uptake was associated with higher HIV stigma scores (AOR = 1.08, 95%CI:1.02,1.16, P = 0.017), a lower level of education (AOR = 2.53, 95%CI: 1.04,6.17, P = 0.0412), and never receiving the flu vaccine (AOR = 15.64, 95%CI:3.66,66.89, P = 0.0002). Participants with at least mild anxiety symptoms (AOR = 0.15, 95%CI:0.03,0.64, P = 0.0107) and a positive attitude towards vaccination (AOR = 0.79, 95%CI: 0.73,0.86, P < 0.0001) were less likely to remain unvaccinated against COVID-19. Conclusions: COVID-19 vaccination campaigns should be tailored for PLWH and incorporate stigma reduction interventions within healthcare settings.
- Open Access
- 24 September 2024
- Published by Springer Nature in Research Square
Trans Health is Public Health: The Prevalence of HIV Among Trans and Gender Expansive People in Kazakhstan
Introduction: Trans and gender expansive (TGE) individuals around the world are at increased risk for contracting HIV and sexually transmitted infections (STIs), yet the combination of stigma, accessibility challenges, and a lack of trans-specific, trans-affirming interventions perpetuates rates of infection. Due to the severe paucity of data on TGE communities and HIV in Central Asia, this study describes HIV infections (both known and newly detected) and STIs among TGE in a multicity Kazakhstan study. Methods: This study utilized behavioral and biological assay data collected in a NIDA-funded clinical trial of a behavioral HIV preventive intervention for substance using cis and trans gay and bisexual men who have sex with men (GBMSM) across three Kazakhstan cities (Almaty, Astana, and Shymkent). We specifically focus on HIV infection, as well as three other STIs (chlamydia, gonorrhea, and syphilis), among 68 TGE individuals who participated in the trial from August 2018 to March 2022. Results: Findings reveal that while the majority (69%) of TGE participants have undergone HIV testing in their lifetime—with 32% having completed an HIV test in the prior 6 months—over a third (37%) of participants did not know their current HIV status. Fourteen (21%) of the participants were confirmed to be living with HIV, and 11 (79%) of these confirmed infections were reportedly unknown prior to testing. STI testing revealed that 47% of the TGE sample tested positive for chlamydia, gonorrhea, or syphilis, with almost 10% testing positive for more than one of these STIs. Conclusions: Findings from this study demonstrate high rates of HIV and STIs among TGE individuals in this sample population in Kazakhstan, as well as a discrepancy between HIV status awareness and confirmed HIV diagnosis (with higher rates of confirmed HIV diagnosis). Additionally, the HIV testing rates fall short of the 90-90-90 and 95-95-95 UNAIDS targets for 2020 and 2030, respectively. These results underscore the need for additional research, interventions, and services to address HIV and other STIs and increase testing—concomitantly redressing the conditions leading to marginalization—among TGE in Kazakhstan. Clinical Trial Number: NCT02786615
- 24 September 2024
- Published by Springer Nature in Research Square
Open AccessTrans Health is Public Health: The Prevalence of HIV Among Trans and Gender Expansive People in Kazakhstan
Introduction: Trans and gender expansive (TGE) individuals around the world are at increased risk for contracting HIV and sexually transmitted infections (STIs), yet the combination of stigma, accessibility challenges, and a lack of trans-specific, trans-affirming interventions perpetuates rates of infection. Due to the severe paucity of data on TGE communities and HIV in Central Asia, this study describes HIV infections (both known and newly detected) and STIs among TGE in a multicity Kazakhstan study. Methods: This study utilized behavioral and biological assay data collected in a NIDA-funded clinical trial of a behavioral HIV preventive intervention for substance using cis and trans gay and bisexual men who have sex with men (GBMSM) across three Kazakhstan cities (Almaty, Astana, and Shymkent). We specifically focus on HIV infection, as well as three other STIs (chlamydia, gonorrhea, and syphilis), among 68 TGE individuals who participated in the trial from August 2018 to March 2022. Results: Findings reveal that while the majority (69%) of TGE participants have undergone HIV testing in their lifetime—with 32% having completed an HIV test in the prior 6 months—over a third (37%) of participants did not know their current HIV status. Fourteen (21%) of the participants were confirmed to be living with HIV, and 11 (79%) of these confirmed infections were reportedly unknown prior to testing. STI testing revealed that 47% of the TGE sample tested positive for chlamydia, gonorrhea, or syphilis, with almost 10% testing positive for more than one of these STIs. Conclusions: Findings from this study demonstrate high rates of HIV and STIs among TGE individuals in this sample population in Kazakhstan, as well as a discrepancy between HIV status awareness and confirmed HIV diagnosis (with higher rates of confirmed HIV diagnosis). Additionally, the HIV testing rates fall short of the 90-90-90 and 95-95-95 UNAIDS targets for 2020 and 2030, respectively. These results underscore the need for additional research, interventions, and services to address HIV and other STIs and increase testing—concomitantly redressing the conditions leading to marginalization—among TGE in Kazakhstan. Clinical Trial Number: NCT02786615
- Open Access
Increasing HIV Testing Among Sexual and Gender Expansive Men in Kazakhstan: A Stepped-Wedge Randomized Trial of a Community-Level Intervention
Importance: HIV transmission in Kazakhstan has increased among men who have sex with men (MSM) and transgender and nonbinary people who have sex with men (TSM), driven by low HIV testing rates. Objective: To determine if the PRIDE in HIV Care intervention had a community effect of increasing HIV testing among MSM and TSM in Kazakhstan. Design: We employed a stepped-wedge, cluster-randomized controlled trial with MSM and TSM community members recruited from three cities in Kazakhstan: Almaty, Astana, and Shymkent. We collected serial cross-sectional data where community members completed one assessment between 21 August 2018, and 30 March 2022. Setting: We collected data from 629 MSM and TSM among the study cities. Community respondents were recruited from real-world (e.g., NGOs, bars, clubs) or virtual sites (e.g., social media, apps) where MSM and TSM in each of the three cities were known to frequent. Participants: Eligibility criteria for community respondents were: (1) ≥18 years old; (2) identifying as male at any point in life or being assigned male at birth; (3) having consensual sex with another man in the past 12 months; (4) engaging in binge drinking (i.e., ≥5 drinks in a 2 hour period), illicit use of drugs, or both in the past 90 days; and (5) residing in one of the three study cities. Intervention: The PRIDE in HIV Care intervention is a theory-driven “crowdsourcing and peer-actuated network intervention” designed to amplify community members’ successes and resilience via “influencers” who can strengthen and impart benefit to their networks and community. Main outcome measures: Received an HIV test in the prior six months. Results: There was a statistically significant increase in odds of recent HIV testing for every additional month the intervention was implemented in a respondent’s city ( AOR =1.08, 95% CI =1.05-1.12; p <.001). Conclusions: The PRIDE in HIV Care intervention appears to be efficacious in enacting a community wide increase—i.e., promoted HIV testing among those who did not go through the intervention itself—in HIV testing among MSM and TSM. Trial Registration: This trial is registered with clinicaltrials.gov ( NCT02786615 ). Funding: National Institute on Drug Abuse (NIDA), grant number R01DA040513. KEY POINTS: Question: Does the PRIDE in HIV Care intervention exert a community effect of increasing HIV testing among men who have sex with men (MSM) and transgender and nonbinary people who have sex with men (TSM) in Kazakhstan? Findings: We employed a stepped-wedge, cluster-randomized controlled trial among three cities in Kazakhstan. There was a statistically significant increase in odds of recent HIV testing for every additional month the intervention was implemented in a respondent’s city. Meaning: The intervention increased HIV testing among MSM and TSM in Kazakhstan who had not directly received the intervention, providing support for a community-wide impact.
Open AccessIncreasing HIV Testing Among Sexual and Gender Expansive Men in Kazakhstan: A Stepped-Wedge Randomized Trial of a Community-Level Intervention
Importance: HIV transmission in Kazakhstan has increased among men who have sex with men (MSM) and transgender and nonbinary people who have sex with men (TSM), driven by low HIV testing rates. Objective: To determine if the PRIDE in HIV Care intervention had a community effect of increasing HIV testing among MSM and TSM in Kazakhstan. Design: We employed a stepped-wedge, cluster-randomized controlled trial with MSM and TSM community members recruited from three cities in Kazakhstan: Almaty, Astana, and Shymkent. We collected serial cross-sectional data where community members completed one assessment between 21 August 2018, and 30 March 2022. Setting: We collected data from 629 MSM and TSM among the study cities. Community respondents were recruited from real-world (e.g., NGOs, bars, clubs) or virtual sites (e.g., social media, apps) where MSM and TSM in each of the three cities were known to frequent. Participants: Eligibility criteria for community respondents were: (1) ≥18 years old; (2) identifying as male at any point in life or being assigned male at birth; (3) having consensual sex with another man in the past 12 months; (4) engaging in binge drinking (i.e., ≥5 drinks in a 2 hour period), illicit use of drugs, or both in the past 90 days; and (5) residing in one of the three study cities. Intervention: The PRIDE in HIV Care intervention is a theory-driven “crowdsourcing and peer-actuated network intervention” designed to amplify community members’ successes and resilience via “influencers” who can strengthen and impart benefit to their networks and community. Main outcome measures: Received an HIV test in the prior six months. Results: There was a statistically significant increase in odds of recent HIV testing for every additional month the intervention was implemented in a respondent’s city ( AOR =1.08, 95% CI =1.05-1.12; p <.001). Conclusions: The PRIDE in HIV Care intervention appears to be efficacious in enacting a community wide increase—i.e., promoted HIV testing among those who did not go through the intervention itself—in HIV testing among MSM and TSM. Trial Registration: This trial is registered with clinicaltrials.gov ( NCT02786615 ). Funding: National Institute on Drug Abuse (NIDA), grant number R01DA040513. KEY POINTS: Question: Does the PRIDE in HIV Care intervention exert a community effect of increasing HIV testing among men who have sex with men (MSM) and transgender and nonbinary people who have sex with men (TSM) in Kazakhstan? Findings: We employed a stepped-wedge, cluster-randomized controlled trial among three cities in Kazakhstan. There was a statistically significant increase in odds of recent HIV testing for every additional month the intervention was implemented in a respondent’s city. Meaning: The intervention increased HIV testing among MSM and TSM in Kazakhstan who had not directly received the intervention, providing support for a community-wide impact.
- Open Access
- 18 July 2024
- Published by Wiley in Journal of the International AIDS Society
- Vol. 27 (S3) , e26320
Mental health and cognition in relation to adherence to antiretroviral therapy among people living with HIV in Kazakhstan: a cross‐sectional study
Introduction: There is a research gap in how mental health and cognition are associated with antiretroviral treatment (ART) adherence among people living with HIV (PLWH) in Kazakhstan.Methods: We randomly selected and enrolled 230 PLWH from the Almaty City AIDS Center registry (June−November 2019) into a cross‐sectional study. We examined associations between self‐reported ART adherence for the last 1 and 2 weeks; the Adherence Self‐Efficacy Scale (ASES) and symptoms of depression (Patient Health Questionnaire‐9 [PHQ‐9]), anxiety (Generalized Anxiety Disorder tool [GAD‐7]), post‐traumatic stress disorder (PTSD Checklist [PTSD]); cognitive function (PROMIS v2.0 Adult Cognitive Function 8a short form) and forgetfulness (Forgetfulness Assessment Inventory). We used cut points of ≥5 for at least mild and ≥10 for at least moderate symptom severity for PHQ‐9 and GAD‐7 and of ≥44 for PTSD. Logistic and linear regression analyses were used.Results: Participants’ median age was 40.0 (IQR: 34−47) with 40.9% (n = 94) of females in the sample. Those who missed at least one pill for the last 2 weeks had higher odds of reporting at least mild depression (aOR = 3.34, 95% CI: 1.22–9.11, p < 0.05); mild anxiety (aOR = 3.27, 95% CI: 1.20–8.92, p < 0.05); and PTSD (aOR = 4.04, 95% CI: 1.15–14.21, p < 0.05) symptoms. Participants who missed at least one pill for the last week had higher odds of at least mild depression (aOR = 7.74, 95% CI: 1.31–45.7, p < 0.05), moderate anxiety (aOR = 21.33, 95% CI: 3.24–140.33, p < 0.005) and PTSD (aOR = 13.81, 95% CI: 2.36–80.84, p < 0.005) symptoms. Participants with better cognitive function had lower odds of non‐adherence over the last week (aOR = 0.88, 95% CI: 0.81–0.96, p < 0.005) and higher ASES scores (β = 0.26, 95% CI: 0.13–0.40, p < 0.005). Poor memory was associated with higher odds of non‐adherence over the last week (aOR = 4.64, 95% CI: 1.76–12.24, p < 0.005) and lower ASES score (β = −0.31, 95% CI: −0.45 to 0.16, p < 0.005). Those who had at least mild depression (β = −0.21, 95% CI: −0.35 to −0.07, p < 0.005); moderate anxiety (β = −0.21, 95% CI: −0.34 to −0.07, p < 0.005) and PTSD (β = −0.19, 95% CI: −0.33 to −0.05, p < 0.005) symptoms had lower ASES scores.Conclusions: Depression, anxiety and PTSD symptoms, poorer cognition, and forgetfulness were associated with poorer ART adherence and worse adherence self‐efficacy. It is crucial to assess and treat mental illness and provide support for PLWH with worsened cognition to enhance ART adherence.
- 18 July 2024
- Published by Wiley in Journal of the International AIDS Society
- Vol. 27 (S3) , e26320
Open AccessMental health and cognition in relation to adherence to antiretroviral therapy among people living with HIV in Kazakhstan: a cross‐sectional study
Introduction: There is a research gap in how mental health and cognition are associated with antiretroviral treatment (ART) adherence among people living with HIV (PLWH) in Kazakhstan.Methods: We randomly selected and enrolled 230 PLWH from the Almaty City AIDS Center registry (June−November 2019) into a cross‐sectional study. We examined associations between self‐reported ART adherence for the last 1 and 2 weeks; the Adherence Self‐Efficacy Scale (ASES) and symptoms of depression (Patient Health Questionnaire‐9 [PHQ‐9]), anxiety (Generalized Anxiety Disorder tool [GAD‐7]), post‐traumatic stress disorder (PTSD Checklist [PTSD]); cognitive function (PROMIS v2.0 Adult Cognitive Function 8a short form) and forgetfulness (Forgetfulness Assessment Inventory). We used cut points of ≥5 for at least mild and ≥10 for at least moderate symptom severity for PHQ‐9 and GAD‐7 and of ≥44 for PTSD. Logistic and linear regression analyses were used.Results: Participants’ median age was 40.0 (IQR: 34−47) with 40.9% (n = 94) of females in the sample. Those who missed at least one pill for the last 2 weeks had higher odds of reporting at least mild depression (aOR = 3.34, 95% CI: 1.22–9.11, p < 0.05); mild anxiety (aOR = 3.27, 95% CI: 1.20–8.92, p < 0.05); and PTSD (aOR = 4.04, 95% CI: 1.15–14.21, p < 0.05) symptoms. Participants who missed at least one pill for the last week had higher odds of at least mild depression (aOR = 7.74, 95% CI: 1.31–45.7, p < 0.05), moderate anxiety (aOR = 21.33, 95% CI: 3.24–140.33, p < 0.005) and PTSD (aOR = 13.81, 95% CI: 2.36–80.84, p < 0.005) symptoms. Participants with better cognitive function had lower odds of non‐adherence over the last week (aOR = 0.88, 95% CI: 0.81–0.96, p < 0.005) and higher ASES scores (β = 0.26, 95% CI: 0.13–0.40, p < 0.005). Poor memory was associated with higher odds of non‐adherence over the last week (aOR = 4.64, 95% CI: 1.76–12.24, p < 0.005) and lower ASES score (β = −0.31, 95% CI: −0.45 to 0.16, p < 0.005). Those who had at least mild depression (β = −0.21, 95% CI: −0.35 to −0.07, p < 0.005); moderate anxiety (β = −0.21, 95% CI: −0.34 to −0.07, p < 0.005) and PTSD (β = −0.19, 95% CI: −0.33 to −0.05, p < 0.005) symptoms had lower ASES scores.Conclusions: Depression, anxiety and PTSD symptoms, poorer cognition, and forgetfulness were associated with poorer ART adherence and worse adherence self‐efficacy. It is crucial to assess and treat mental illness and provide support for PLWH with worsened cognition to enhance ART adherence.
- Open Access
Social Impacts of Multi-City HIV Research Participation Among Sexual and Gender Expansive Individuals in Kazakhstan
Background : Sexual and gender expansive (SGE) individuals in Kazakhstan are disproportionately affected by HIV yet stigma and discrimination pose ethical and practical challenges for HIV prevention research involving them. Although researchers are tasked with ensuring that risks of research participation are reasonable in relation to its benefits, participation-related risks and benefits—including negative and positive social impacts (NSIs and PSIs respectively) on personal relationships, social status, health, and other aspects of life—among SGE populations have received little attention. Methods : We examined NSIs and PSIs of participation among SGE individuals in a three-city HIV prevention study in Kazakhstan at the clinical trial's follow-up visits. We analyzed responses from 579 unique SGE participants who completed a total of 2648 follow-up visits over the 36-month study period (2019–2022). Results : Overall, NSIs were rare: 9 (2%) participants reported NSIs during the study; virtually no NSIs (mean=0.0037, SD=0.03) were reported at each follow-up visit. These few NSIs included 'trouble with friends, family, or acquaintances' and 'other'. By contrast, PSIs were extensive: 515 (89%) participants reported PSIs during the study; almost an average of five PSIs (mean=4.8, SD=3.4) were reported at each follow-up visit. The most endorsed PSIs were 'gained knowledge', 'improvement in HIV-related issues', and 'improvement in life'. Conclusions : Our findings demonstrate the potential for HIV prevention research to be associated with PSIs for SGE individuals experiencing stigmatization and discrimination. Future research should address NSIs, particularly interpersonal challenges among network members, within HIV prevention research to minimize risks and burdens of participation.
Open AccessSocial Impacts of Multi-City HIV Research Participation Among Sexual and Gender Expansive Individuals in Kazakhstan
Background : Sexual and gender expansive (SGE) individuals in Kazakhstan are disproportionately affected by HIV yet stigma and discrimination pose ethical and practical challenges for HIV prevention research involving them. Although researchers are tasked with ensuring that risks of research participation are reasonable in relation to its benefits, participation-related risks and benefits—including negative and positive social impacts (NSIs and PSIs respectively) on personal relationships, social status, health, and other aspects of life—among SGE populations have received little attention. Methods : We examined NSIs and PSIs of participation among SGE individuals in a three-city HIV prevention study in Kazakhstan at the clinical trial's follow-up visits. We analyzed responses from 579 unique SGE participants who completed a total of 2648 follow-up visits over the 36-month study period (2019–2022). Results : Overall, NSIs were rare: 9 (2%) participants reported NSIs during the study; virtually no NSIs (mean=0.0037, SD=0.03) were reported at each follow-up visit. These few NSIs included 'trouble with friends, family, or acquaintances' and 'other'. By contrast, PSIs were extensive: 515 (89%) participants reported PSIs during the study; almost an average of five PSIs (mean=4.8, SD=3.4) were reported at each follow-up visit. The most endorsed PSIs were 'gained knowledge', 'improvement in HIV-related issues', and 'improvement in life'. Conclusions : Our findings demonstrate the potential for HIV prevention research to be associated with PSIs for SGE individuals experiencing stigmatization and discrimination. Future research should address NSIs, particularly interpersonal challenges among network members, within HIV prevention research to minimize risks and burdens of participation.